07/08/2025 04:00
Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Through this collaboration, LabPMM (Invivoscribe’s global reference laboratories) have customized their multiparametric flow cytometry (MFC) services and implemented their sensitive MFC AML MR...

07/08/2025 04:00
Tigo Energy Adds Solar-Plus-Storage Portfolio in Czech Republic to Build on MLPE Success

Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced that the Company’s entire portfolio of three-phase Tigo EI Inverters has successfully passed the certification tests for compliance with the PPDS P4 requirements in the Czech Republic. Compliance with PPDS P4, formally known as Distribution System Operation Rules, Annex 4, is a prerequisite for grid connection of solar inverters in the Czech Republic, va...

AFP journalists Christina Assi and Dylan Collins to speak at the Press Freedom Center Forum

AFP journalists Christina Assi and Dylan Collins will speak at the Press Freedom Center Forum to share their experience of the Israeli shelling in southern Lebanon on 13 October 2023. The event will take place on 12 March 2025 at the National Press Club in Washington, D.C.

AFP journalists Christina Assi and Dylan Collins will speak at the Press Freedom Center Forum to share their experience of the Israeli shelling in southern Lebanon on 13 October 2023. The event will take place on 12 March 2025 at the National Press Club in Washington, D.C.
Subscribe to